Insulet
PODD
483 hedge funds and large institutions have $18.9B invested in Insulet in 2022 Q1 according to their latest regulatory filings, with 69 funds opening new positions, 191 increasing their positions, 161 reducing their positions, and 55 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 4 → 8 (+4)
25% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 55
19% more repeat investments, than reductions
Existing positions increased: 191 | Existing positions reduced: 161
16% more call options, than puts
Call options by funds: $47.6M | Put options by funds: $41M
2% more funds holding
Funds holding: 475 → 483 (+8)
1% more capital invested
Capital invested by funds: $18.6B → $18.9B (+$237M)
0.75% more ownership
Funds ownership: 101.67% → 102.42% (+0.75%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$758M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
+$258M |
| 3 |
William Blair Investment Management
Chicago,
Illinois
|
+$126M |
| 4 |
ClearBridge Investments
New York
|
+$116M |
| 5 |
ESCM
Echo Street Capital Management
New York
|
+$74.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$571M |
| 2 |
Capital Research Global Investors
Los Angeles,
California
|
-$216M |
| 3 |
Coatue Management
New York
|
-$135M |
| 4 |
Norges Bank
Oslo,
Norway
|
-$87.6M |
| 5 |
FAM
Fred Alger Management
New York
|
-$67.8M |
PODD Hedge Fund Activity: Q1 2022 in Review
483 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q1 2022, worth a combined $18.9B — up 1.3% from $18.6B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new PODD positions and 55 closed out — a net gain of 14 holders — while 191 added to existing stakes and 161 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $758M. The largest seller was Capital World Investors, cutting an estimated $571M.
- 483 institutional investors held Insulet (PODD) as of Q1 2022, up from 475 in Q4 2021.
- Funds reported $18.9B of Insulet stock for Q1 2022, up 1.3% quarter-over-quarter.
- 69 funds opened new Insulet positions in Q1 2022 and 55 closed out, a net change of +14 holders.
- The largest Insulet buyer in Q1 2022 was T. Rowe Price Associates, an estimated $758M added.
- The largest Insulet seller in Q1 2022 was Capital World Investors, an estimated $571M sold.
Based on aggregated 13F filings for Q1 2022.